Revance Therapeutics, Inc


Updates from The Motley Fool

Latest updates on Revance Therapeutics from Fool.com.


Stock Performance

RVNC vs. S&P 500 | 2 Year Performance
View Interactive RVNC Charts
Sponsored by

Key Data Points

Primary metrics and data points about Revance Therapeutics.
Current Price: $14.19
Prev Close: $14.29
Open: $14.32
Bid: $14.19
Ask: $14.21
Day's Range: $13.80 - $14.58
52wk Range: $12.54 - $42.41
Volume: 97,645
Avg Vol 420,262
Market Cap: $398.21M
P/E (ttm): -4.64
EPS (ttm): -$3.08
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Revance Therapeutics.
CAPS Rating 2 out of 5
 
15 Outperform
2 Underperform
CAPS All Stars
 
4 Outperform
2 Underperform

How do you think Revance Therapeutics will perform against the market?



You pick for Revance Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Revance Therapeutics.

Revance Therapeutics, Inc

  • Exchange: NASDAQ